India Globalization Capital (NYSE American: IGC) today announced that its CEO Ram Mukunda and PFO Claudia Grimaldi will be featured in an investor webinar hosted by Radius Research. Beginning at 12:30 p.m. ET on Friday, Feb. 10, Mukunda and Grimaldi will discuss the company’s phase 2 trial for its drug candidate IGC-AD1 in treating agitation…
Silo Pharma (NASDAQ: SILO), a developmental-stage biopharmaceutical company, recently provided a progress update on its sponsored clinical trial with the University of California, San Francisco (“UCSF”) examining the effect of psilocybin on inflammation. “Silo’s sponsored clinical trial with the Clinical & Translational Science Institute at UCSF aims to validate the use of psilocybin as a…
Eloro Resources (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM), an exploration and mine development company with a portfolio of gold and base-metal properties in Bolivia, Peru and Quebec, boasts one of the most potentially significant silver and tin deposits within the Cerro Rico region and has recently looked to expand its addressable deposit through the acquisition…
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, announced that enrollment is continuing in its ongoing global trial evaluating Berubicin for the treatment of recurrent glioblastoma multiforme (“GBM”). Specifically, the company is reporting that it has enrolled the first…
Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots, today announced that its Robot Roadshow will land at Silverton Hotel & Casino in Las Vegas, Nevada, from 10:00 a.m. to 2:00 p.m. PT on Feb. 7-9, 2023. The engaging experiential event is designed to grab attention, forge direct connections with potential clients, and strike…
Eloro Resources (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM), an exploration and mine development company with a portfolio of gold and base-metal properties in Bolivia, Peru and Quebec, recently announced that it has granted an aggregate of 300,000 restricted share units (the “RSUs”) to its senior officers pursuant to its long-term incentive plan. The company’s plan…
BiondVax Pharmaceuticals (NASDAQ: BVXV), a biotech company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases, is the subject of an updated report released from Aegis Capital Corp. The update reflects the strong results from BVXV’s latest animal study indicating that anti-COVID-19 NanoAb can prevent infection.…
Correlate Infrastructure Partners (OTCQB: CIPI), a tech-enabled distributed energy solutions company, foresees exciting new opportunities available thanks to the government’s emphasis on driving the country toward a future free of its dependence on carbon fuel and otherwise inefficient utilities. “Correlate is focused on helping companies that develop and rent out commercial building properties succeed at…
HeartBeam (NASDAQ: BEAT) is a cardiac technology company that is leading the way in identifying heart attacks by developing a personal, portable and easy-to-use heart-attack detection solution. “The company has two patented products in development: HeartBeam AIMI(TM), software for acute care settings that provides a 3D comparison of baseline and symptomatic 12-lead ECG to more…
McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) is an asset-rich diversified gold and silver producer in the Americas. In addition, the company has a large exposure to copper through its subsidiary McEwen Copper, owner of the Los Azules copper deposit in Argentina, believed to be the 9th largest undeveloped copper resource in the world. “McEwen…
CNS Pharmaceuticals (NASDAQ: CNSP) recently reported that 67 patients have enrolled in the potentially pivotal phase 2 globally cited clinical study comparing drug candidate Berubicin’s effectiveness to second-line standard-of-care chemotherapy drug Lomustine. “The company plans to have more than 200 patients participate in the clinical trial on a 2:1 randomization schema between those receiving Berubicin…
BiondVax (NASDAQ: BVXV), a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases, today announced that its CEO Amir Reichman will present at the BIO CEO & Investor Conference. The event is slated to take place in New York from Feb. 6-9, 2023. Reichman’s…
Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, has developed its patented DehydraTECH(TM) technology, which is designed for formulating and delivering lipophilic (fat-soluble) drugs and active ingredients. “DehydraTECH increases effectiveness and improves how these ingredients enter the bloodstream. Benefits of DehydraTECH include: improved speed of onset, with effects felt in minutes;…
Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and emergency systems, announced that it has entered five new contracts outlining sales for 13 more machines. The momentum the company created last year is carrying into 2023. The new contracts include a Portland private equity real estate investment firm, which signed a contract for…
Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today announced that the U.S. Patent and Trademark Office (“USPTO”) has issued U.S. Patent 11,491,120, titled “Pharmacological Prophylactics Against Stress-Induced Affective Disorders in Females.” The patent’s allowed claims protect the use of portfolio drug SPC-15 in a method…
Data443 Risk Mitigation (OTC: ATDS) has emerged as a key player within the cyber security space, strategically positioned to benefit from increased demand for data protection with its portfolio of software solutions that allow for a unified approach to data governance and security. “In addition to its ransomware recovery and data protection services, Data443’s extensive…
EverGen (TSX.V: EVGN) (OTCQB: EVGIF), Canada’s renewable natural gas (“RNG”) infrastructure platform, is featured in an editorial published by NetworkNewsWire (“NNW”). The editorial discusses the booming market for renewable energy; much of the growth is rooted in growing concerns about climate change, energy security and global initiatives to reign in carbon emissions. To add to the momentum,…
Jupiter Wellness (NASDAQ: JUPW), a company focused on hair, skin and sexual wellness, today announced that Dr. Hector Alila has rejoined its board of directors with the specific responsibility of building a technical advisory board. “We are pleased to welcome Hector back to our board. With our focus on new scientific and clinical programs, our…
Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), has received key approval to initiate human dosing of CYB004, its proprietary deuterated N,N-dimethyltryptamine (“DMT”) molecule, through a protocol amendment to its ongoing CYB004-E phase 1 trial. The approval came from an independent ethics committee in the Netherlands. The first-ever trial…
Eloro Resources (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) executive VP of exploration Bill Pearson was a spotlighted guest during the latest The Power Play by The Market Herald interview. During the segment, Peterson and host Sabrina Cuthbert discussed the latest news from Eloro Resources concerning assay results from additional diamond drill holes from the Iska…